Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Discovery of a Novel Triple Negative Breast Cancer Biomarker that Regulates Tumor Invasiveness

EF 2015-16

Résumé
A subset of all breast cancers are classified as basal-like, a subtype with a poor 5-year prognosis. Cells in these tumours exhibit mesenchymal properties, meaning they lack a strong structural framework and can migrate more easily. Consequently, the transition to this cell type, known as the epithelial to mesenchymal transition (EMT) and regulated by key factors, is thought to be critical in the increase of disease invasion and spread. This transition has also been linked to the formation of cancer stem cells (CSCs), a subpopulation of tumour cells which have the ability to self-renew and form new tumours. Our lab has recently identified a unique protein, referred to as SRCA, which is primarily seen in these highly aggressive cancers, and is regulated by the key transition factors involved in EMT. I propose that SRCA plays a key role in regulating basal-like breast cancer spread and recurrence via its involvement in EMT programming and stemness. To determine if this protein is necessary for transition and the formation of stem-like cells, I will artificially silence it in normal human breast cells whose EMT programming can be turned on, and monitor them for transitional changes, markers of stemness, and their ability to migrate and form new tumours both in the lab and in mice. Conversely, to investigate if SRCA is a driver of the EMT process and tumour formation, I will overexpress SRCA in normal human breast cells and measure cell transformation, stemness, and their ability to form new tumours. Moreover, we can breed mice that normally develop metastatic cancer with others to remove all SRCA protein levels in the breast tissue to determine if its absence can halt tumour development and spread.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
350191
Name
Polenz Chanele
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Discovery of a Novel Triple Negative Breast Cancer Biomarker that Regulates Tumor Invasiveness
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Diagnostics; Emt; Invasion; Metastasis; Stemness; Therapy
Abstract
A subset of all breast cancers are classified as basal-like, a subtype with a poor 5-year prognosis. Cells in these tumours exhibit mesenchymal properties, meaning they lack a strong structural framework and can migrate more easily. Consequently, the transition to this cell type, known as the epithelial to mesenchymal transition (EMT) and regulated by key factors, is thought to be critical in the increase of disease invasion and spread. This transition has also been linked to the formation of cancer stem cells (CSCs), a subpopulation of tumour cells which have the ability to self-renew and form new tumours. Our lab has recently identified a unique protein, referred to as SRCA, which is primarily seen in these highly aggressive cancers, and is regulated by the key transition factors involved in EMT. I propose that SRCA plays a key role in regulating basal-like breast cancer spread and recurrence via its involvement in EMT programming and stemness. To determine if this protein is necessary for transition and the formation of stem-like cells, I will artificially silence it in normal human breast cells whose EMT programming can be turned on, and monitor them for transitional changes, markers of stemness, and their ability to migrate and form new tumours both in the lab and in mice. Conversely, to investigate if SRCA is a driver of the EMT process and tumour formation, I will overexpress SRCA in normal human breast cells and measure cell transformation, stemness, and their ability to form new tumours. Moreover, we can breed mice that normally develop metastatic cancer with others to remove all SRCA protein levels in the breast tissue to determine if its absence can halt tumour development and spread.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Polenz, Chanele
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~